Parliamentary QA
Enabling Low-Income Seniors Access to Shingles Vaccines
22 November 2023
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
NOTICE PAPER NO. 2398
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR THE SITTING OF PARLIAMENT ON 22 NOVEMBER 2023
Name and Constituency of Member of Parliament
Mr Murali Pillai
MP for Bukit Batok
Question No. 5214
To ask the Minister for Health having regard to the fact that more than 90% of Singaporeans of and above the age of 50 carry dormant varicella-zoster virus and a study in the US suggesting that up to 1 in 3 adults can experience the reactivation of the virus in the form of shingles, whether the Government will study ways to enable seniors from low-income backgrounds to have access to shingles vaccines which are currently viewed as expensive.
Answer
The Ministry of Health is currently evaluating the shingles vaccine’s clinical and cost-effectiveness, with a view to decide if it should be included in the National Adult Immunisation Schedule (NAIS). If yes, it will be eligible for subsidies and MediSave usage.